STE STERIS plc

Price (delayed)

$214.54

Market cap

$21.4B

P/E Ratio

63.47

Dividend/share

$1.63

EPS

$3.38

Enterprise value

$24.71B

Steris Corporation is an American Irish-domiciled medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, but has been ...

Highlights
The company's equity has surged by 89% YoY and by 69% QoQ
STE's gross profit is up by 14% year-on-year and by 10% since the previous quarter
STERIS's debt has soared by 113% from the previous quarter
STE's P/E is 66% above its 5-year quarterly average of 38.5 and 46% above its last 4 quarters average of 43.6

Key stats

What are the main financial stats of STE
Market
Shares outstanding
99.76M
Market cap
$21.4B
Enterprise value
$24.71B
Valuations
Price to earnings (P/E)
63.47
Price to book (P/B)
2.79
Price to sales (P/S)
5.38
EV/EBIT
57.21
EV/EBITDA
36.03
EV/Sales
7.25
Earnings
Revenue
$3.41B
EBIT
$431.82M
EBITDA
$685.72M
Free cash flow
$424.8M
Per share
EPS
$3.38
Free cash flow per share
$4.98
Book value per share
$77.01
Revenue per share
$39.91
TBVPS
$44.12
Balance sheet
Total assets
$12.1B
Total liabilities
$5.52B
Debt
$3.84B
Equity
$6.57B
Working capital
$862.84M
Liquidity
Debt to equity
0.58
Current ratio
1.75
Quick ratio
1.12
Net debt/EBITDA
4.82
Margins
EBITDA margin
20.1%
Gross margin
43.6%
Net margin
8.4%
Operating margin
13.2%
Efficiency
Return on assets
3.7%
Return on equity
6.4%
Return on invested capital
10.6%
Return on capital employed
3.9%
Return on sales
12.7%
Dividend
Dividend yield
0.76%
DPS
$1.63
Payout ratio
48.2%

STE stock price

How has the STERIS stock price performed over time
Intraday
-0.41%
1 week
2.3%
1 month
-5%
1 year
25.09%
YTD
13.19%
QTD
3.99%

Financial performance

How have STERIS's revenue and profit performed over time
Revenue
$3.41B
Gross profit
$1.48B
Operating income
$448.69M
Net income
$287.4M
Gross margin
43.6%
Net margin
8.4%
STERIS's net margin has decreased by 39% YoY and by 34% from the previous quarter
The company's net income fell by 30% YoY and by 28% QoQ
STE's operating margin is down by 27% year-on-year and by 25% since the previous quarter
STE's operating income is down by 18% from the previous quarter and by 17% YoY

Growth

What is STERIS's growth rate over time

Valuation

What is STERIS stock price valuation
P/E
63.47
P/B
2.79
P/S
5.38
EV/EBIT
57.21
EV/EBITDA
36.03
EV/Sales
7.25
STE's P/E is 66% above its 5-year quarterly average of 38.5 and 46% above its last 4 quarters average of 43.6
The company's EPS fell by 31% YoY and by 27% QoQ
The company's equity has surged by 89% YoY and by 69% QoQ
STE's P/B is 26% below its last 4 quarters average of 3.8 and 10% below its 5-year quarterly average of 3.1
The P/S is 46% above the 5-year quarterly average of 3.7 and 3.8% above the last 4 quarters average of 5.2
The revenue has grown by 13% YoY and by 10% from the previous quarter

Efficiency

How efficient is STERIS business performance
STERIS's ROA has plunged by 52% YoY and by 44% from the previous quarter
The ROE has decreased by 48% YoY and by 40% from the previous quarter
STERIS's ROIC has decreased by 43% YoY and by 37% from the previous quarter
The company's return on sales fell by 30% YoY and by 29% QoQ

Dividends

What is STE's dividend history
DPS
$1.63
Dividend yield
0.76%
Payout ratio
48.2%
Recent dividends

Financial health

How did STERIS financials performed over time
The total assets is 119% more than the total liabilities
STE's total liabilities has surged by 194% year-on-year and by 106% since the previous quarter
The total assets has soared by 126% YoY and by 84% from the previous quarter
STERIS's debt is 42% less than its equity
STERIS's debt has soared by 113% from the previous quarter
The company's equity has surged by 89% YoY and by 69% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.